Resilience and Satir Model Training for Adolescent Depression

Not Applicable

Completed

• Conditions: Adolescent Depression

• Registration Number: NCT07063485
• Lead Sponsor: The First Hospital of Hebei Medical University

Brief Summary

This randomized controlled trial aims to assess the effectiveness of an intervention combining resilience theory with Satir model nursing skills training compared to routine nursing care for adolescents with depression. The study evaluates changes in depressive symptoms, psychological resilience, self-esteem, coping styles, and medication adherence.

Detailed Description

Adolescent depression is a growing mental health concern with significant impacts on academic and social functions. While psychological interventions are crucial, conventional methods may have limitations. This study introduces and evaluates a novel intervention that integrates resilience theory, focusing on patients' strengths and potential, with the Satir model, which addresses psychological issues from individual, family, and social systems. The study randomized 182 adolescents with depression into two groups: a research group receiving the integrated intervention and a control group receiving routine nursing care. The primary objective is to determine if the comprehensive intervention is more effective in alleviating depressive symptoms and improving psychological well-being, including resilience, self-esteem, and coping mechanisms. The findings aim to provide evidence for a new, effective therapeutic strategy for this vulnerable population.

Study Timeline

• Study Start: 2022-02-01
• Primary Completion: 2023-06-30
• Study Completion: 2023-06-30
• Status Verified: 2025-07
• Study First Submitted: 2025-07-03
• Study First Submitted QC: 2025-07-03
• Last Update Submitted: 2025-07-12
• Study First Posted: 2025-07-14
• Last Update Posted: 2025-07-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 182

Inclusion Criteria

• Diagnosis aligning with the ICD-10 criteria for depressive episodes.
• First onset with a course between 4 weeks and 12 months.
• Age between 13 and 18 years.
• Normal communication ability.
• No antidepressant use in the four weeks preceding admission, and no prior psychological treatment.
• HAMD-24 score exceeding 20 points.
• Informed consents from family members or guardians.

Exclusion Criteria

• Participants withdrawing prematurely.
• Presence of organic lesions.
• Antidepressant or psychological treatment before enrollment.
• Allergic constitution.
• Depression induced by physical illness.
• Suicide ideation score ≥4 points in MADRS with suicidal tendency.
• Diagnosis of bipolar affective disorder.
• Coexistence of other mental illnesses.
• Neurological diseases or substance dependence/abuse.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Depressive Symptoms as measured by the 17-item Hamilton Depression Scale (HAMD-17)	Baseline (at admission) and 3 Months Post-intervention	The HAMD-17 is a clinician-rated scale with 17 items scored on a 0-4 or 0-2 point scale. A higher total score indicates more severe depressive symptoms.
Change in Depressive Symptoms as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS)	Baseline (at admission) and 3 Months Post-intervention	The MADRS is a 10-item clinician-rated scale, with each item scored from 0-6. The total score ranges from 0-60, with higher scores indicating more severe depression.
Change in Depressive Symptoms as measured by the Beck Depression Inventory (BDI)	Baseline (at admission) and 3 Months Post-intervention	The BDI is a 13-item self-report questionnaire where items are scored from 0-3. Higher total scores indicate more severe depression.

Secondary Outcome Measures

Name	Time	Method
Change in Self-Esteem Level as measured by the Feelings of Inferiority Scale (FIS)	Baseline (at admission) and 3 Months Post-intervention	The FIS is a 36-item scale assessing dimensions of self-esteem, social confidence, learning ability, appearance, and experience, scored from 0-6. A higher score indicates stronger self-esteem.
Change in Medication Compliance as measured by the Medication Adherence Rating Scale (MARS)	Baseline (at admission) and 3 Months Post-intervention	The MARS is a 10-item scale assessing medication compliance behaviors and attitudes. The total score ranges from 0 to 10. A higher score indicates better medication compliance.
Change in Coping Styles as measured by the Simplified Coping Style Questionnaire (SCSQ)	Baseline (at admission) and 3 Months Post-intervention	The SCSQ is a 20-item questionnaire measuring positive coping (12 items) and negative coping (8 items). Scores range from 0-3. Higher scores on each subscale indicate a greater inclination toward that coping style.
Change in Psychological Resilience as measured by the Resilience Scale for Chinese Adolescents (RSCA)	Baseline (at admission) and 3 Months Post-intervention	The RSCA is a 27-item scale assessing five dimensions: interpersonal assistance, family support, positive cognition, emotional control, and goal focus. The total score ranges from 27 to 135. Higher scores indicate higher levels of psychological resilience.

Trial Locations

Locations (1)

The First Hospital of Hebei Medical University; 🇨🇳 Shijiazhuang, Hebei, China